Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-8-5
|
pubmed:abstractText |
A novel human EBV-negative B-cell line, designated DOBIL-6, was established from a patient with non-secretary myeloma. The DOBIL-6 cell has cytoplasmic gamma protein and expresses CD19, 20, 38, 45RO, VLA-4 and PCA-1 antigens, but lacks CD10, 45RA and VLA5 antigens. Chromosome analysis showed that DOBIL-6 cells had many complex structural abnormalities, including t(11;4) (q13;q32), which were consistent with that of the fresh tumour cells. Interestingly, abundant interleukin-6 (IL-6) and parathyroid hormone-related protein (PTHrP) accumulated in the culture supernatant of DOBIL-6 cells. Hypercalcaemia and splenomegaly associated with plasma cell proliferations which resulted in the expansion of the light zones in the follicles were observed in DOBIL-6 transplanted nude mice. RT-PCR analysis detected mRNA for PTHrP, and IL-6 as well as its receptor (GP80) in DOBIL-6 cells. Treatment of the DOBIL-6 cells with neutralizing anti-IL-6 antibody inhibited their growth in a dose-dependent manner, whereas the addition of exogenous IL-6 stimulated it in serum-depleted conditions. These findings suggest that both IL-6 and PTHrP are produced in DOBIL-6 cells, and that IL-6 promotes its growth by an autocrine mechanism. Since IL-6 is known to stimulate not only the growth of B-cell neoplasms but also osteoclastic bone resorption by cooperating with PTHrP, this simultaneous production of IL-6 and PTHrP might be synergistically linked and play a role in the development of hypercalcaemia of the patient. The DOBIL-6 cell is a useful tool to clarify the mechanism of hypercalcaemia associated with mature B-cell neoplasms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
688-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9674742-Aged,
pubmed-meshheading:9674742-B-Lymphocytes,
pubmed-meshheading:9674742-Chromosomes, Human, Pair 11,
pubmed-meshheading:9674742-Chromosomes, Human, Pair 14,
pubmed-meshheading:9674742-Fatal Outcome,
pubmed-meshheading:9674742-Female,
pubmed-meshheading:9674742-Humans,
pubmed-meshheading:9674742-Hypercalcemia,
pubmed-meshheading:9674742-Interleukin-6,
pubmed-meshheading:9674742-Karyotyping,
pubmed-meshheading:9674742-Multiple Myeloma,
pubmed-meshheading:9674742-Parathyroid Hormone-Related Protein,
pubmed-meshheading:9674742-Phenotype,
pubmed-meshheading:9674742-Polymerase Chain Reaction,
pubmed-meshheading:9674742-Proteins,
pubmed-meshheading:9674742-Translocation, Genetic,
pubmed-meshheading:9674742-Tumor Cells, Cultured
|
pubmed:year |
1998
|
pubmed:articleTitle |
A novel mature B-cell line (DOBIL-6) producing both parathyroid hormone-related protein and interleukin-6 from a myeloma patient presenting with hypercalcaemia.
|
pubmed:affiliation |
First Department of Internal Medicine, Kagawa Medical University, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|